Enamel Matrix Derivatives & Periodontal Therapy in Diabetic Patients

Author(s):  
Materials ◽  
2019 ◽  
Vol 12 (17) ◽  
pp. 2790
Author(s):  
Nicola Discepoli ◽  
Raffaele Mirra ◽  
Marco Ferrari

Background: The systematic review was designed to answer the following focused question: Are enamel matrix derivatives able to improve the quantity of keratinized tissue (KT) around natural dentition in patients with recessions defects after their treatment with periodontal plastic procedures? Methods: Only Randomized Clinical Trials (RCT) in English language evaluating root coverage procedures in combination with enamel matrix derivatives (commercially known as Emdogain®—EMD), with at least 10 subjects and a minimum duration of six months, were included. The search was applied to PUBMED and SCOPUS and it consists of a combination of MeSH terms and free text words (from January 2000 to June 2019). Risk of bias in individual studies and across studies was also evaluated. Results: After the full text analysis and the exclusion of further 18 articles, 12 articles were finally included. In total 639 recessions were treated (334 tests and 305 control). The recessions defects were classified according to the classification of Miller (Class I, II, III, IV). Only one trial included Miller Class III recessions (7 in total). Enamel matrix derivatives were applied in conjunction with Coronally Advanced Flap (CAF), Coronally Advanced Flap + Sub Epithelial Connective Tissue Graft (CAF + CTG), Semilunar Flap (SF). For the group CAF vs CAF + EMD the mean difference between the keratinized tissue gain in the two procedures was 0.40 mm (95% Confindence Interval Lower/Upper: 0.014–0.81) (p < 0.058); for the comparison CAF + CTG + EMD vs. CAF + CTG the mean difference between the two groups resulted in −0.06 mm (95% Confindence Interval Lower Upper −0.45 to 0.33) (p = 0.7603). Discussion: Randomized clinical trials included medium-low quality evidence. The application of Enamel Matrix Derivatives to surgical procedures aimed to cover gingival recessions does not add robust clinical benefit to conventional plastic procedure alone.


2007 ◽  
Vol 329 (2) ◽  
pp. 283-294 ◽  
Author(s):  
Philippe Kémoun ◽  
Sara Laurencin-Dalicieux ◽  
Jacqueline Rue ◽  
Jean-Christophe Farges ◽  
Isabelle Gennero ◽  
...  

Biomaterials ◽  
2011 ◽  
Vol 32 (30) ◽  
pp. 7375-7388 ◽  
Author(s):  
Philippe Kémoun ◽  
Stan Gronthos ◽  
Malcolm L. Snead ◽  
Jacqueline Rue ◽  
Bruno Courtois ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document